FREE SHIPPING ON ORDERS OVER $150

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

$21.97

Quantity
- +
Description

Refrigerate promptly

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

Product Specifications Compound: 5-Amino-1MQ (5-Amino-1-Methylquinolinium) Class: Synthetic small molecule / methylquinolinium compound Molecular Formula: CHN Molecular Weight: ~159 Da (cation

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

(PubMed) Sauberlich HE

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

Each unit on the syringe equals 0.01 mL

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

Skorjanec S, Kokot A, Drmic D, et al

foxo4-dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells The disordered p53 transactivation domain

You may also like

recommand products